Ligand validation:4UGO

H4B: 5,6,7,8-TETRAHYDROBIOPTERIN

H4B is a Ligand Of Interest in 4UGO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UGO_H4B_A_902	54%	5%	0.164	0.928	1.86	3.36	2	6	0	0	100%	1
5G68_H4B_A_902	78%	13%	0.112	0.955	1.43	2.51	2	8	0	0	100%	1
4UGY_H4B_A_902	73%	8%	0.117	0.945	1.61	3	2	8	0	0	100%	1
4UGK_H4B_A_902	72%	8%	0.114	0.938	1.6	3	2	7	0	0	100%	1
4D7J_H4B_A_902	68%	11%	0.12	0.932	1.58	2.53	2	6	0	0	100%	1
4UGN_H4B_A_902	66%	10%	0.149	0.956	1.66	2.63	2	6	0	0	100%	1
4CWW_H4B_A_600	100%	14%	0.04	0.981	1.05	2.79	2	6	1	0	100%	1
4CU1_H4B_B_600	99%	20%	0.042	0.98	1.17	2.2	2	5	1	0	100%	1
4CWZ_H4B_A_600	99%	15%	0.045	0.978	0.83	2.85	-	7	1	0	100%	1
4UPR_H4B_B_600	99%	15%	0.047	0.974	1.18	2.58	1	6	1	0	100%	1
7TS4_H4B_D_803	98%	20%	0.055	0.979	0.86	2.5	-	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.